IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PAVANELLO, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.816
NA - Nord America 3.075
AS - Asia 2.040
SA - Sud America 150
OC - Oceania 77
AF - Africa 63
Continente sconosciuto - Info sul continente non disponibili 6
Totale 10.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.852
GB - Regno Unito 1.382
IT - Italia 1.180
CN - Cina 850
DE - Germania 834
SE - Svezia 262
IN - India 201
SG - Singapore 195
JP - Giappone 182
FR - Francia 167
IE - Irlanda 161
CA - Canada 133
TR - Turchia 130
ES - Italia 122
DK - Danimarca 100
HK - Hong Kong 92
TW - Taiwan 85
RU - Federazione Russa 84
MX - Messico 73
AU - Australia 67
KR - Corea 64
NL - Olanda 64
FI - Finlandia 63
ID - Indonesia 62
BR - Brasile 57
PL - Polonia 50
AT - Austria 48
CH - Svizzera 44
BE - Belgio 41
UA - Ucraina 39
AR - Argentina 31
IR - Iran 30
RO - Romania 30
CO - Colombia 28
ZA - Sudafrica 27
VN - Vietnam 26
GR - Grecia 24
PT - Portogallo 23
MY - Malesia 21
CZ - Repubblica Ceca 20
HU - Ungheria 20
SA - Arabia Saudita 20
CL - Cile 16
JO - Giordania 15
RS - Serbia 15
TH - Thailandia 13
EG - Egitto 10
NZ - Nuova Zelanda 10
IL - Israele 9
PK - Pakistan 8
SC - Seychelles 8
CR - Costa Rica 7
HR - Croazia 7
QA - Qatar 7
AE - Emirati Arabi Uniti 6
ET - Etiopia 6
BG - Bulgaria 5
EC - Ecuador 5
MA - Marocco 5
NO - Norvegia 5
PE - Perù 5
PH - Filippine 5
SK - Slovacchia (Repubblica Slovacca) 5
LV - Lettonia 4
PS - Palestinian Territory 4
SI - Slovenia 4
SV - El Salvador 4
EE - Estonia 3
EU - Europa 3
IQ - Iraq 3
IS - Islanda 3
LB - Libano 3
LT - Lituania 3
OM - Oman 3
PR - Porto Rico 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
BO - Bolivia 2
LK - Sri Lanka 2
ME - Montenegro 2
NP - Nepal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AP - ???statistics.table.value.countryCode.AP??? 1
BH - Bahrain 1
BZ - Belize 1
CU - Cuba 1
DZ - Algeria 1
GG - Guernsey 1
GH - Ghana 1
HN - Honduras 1
KE - Kenya 1
LI - Liechtenstein 1
MW - Malawi 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 10.227
Salva come PNG Salva come JPEG
Città #
Southend 1.104
Milan 347
Hanover 296
Frankfurt am Main 265
Chandler 248
Fairfield 224
Redwood City 191
Wilmington 167
Seattle 147
Dublin 140
Houston 140
Ashburn 127
Woodbridge 121
Beijing 111
Ann Arbor 109
Singapore 105
Princeton 103
Cambridge 98
Dearborn 85
Nanjing 80
Istanbul 73
Rome 68
Taipei 61
Shanghai 59
Grafing 58
New York 57
Hong Kong 55
Toronto 52
Bengaluru 48
Jakarta 41
Helsinki 40
Fuzhou 39
Turin 37
Jinan 36
Des Moines 34
Guangzhou 34
Paris 30
Shenyang 30
San Diego 27
Berlin 26
Genoa 26
Boardman 25
Phoenix 25
London 24
Madrid 23
Tokyo 23
Magenta 21
Vienna 21
Delhi 20
Changsha 19
Tianjin 19
Fremont 18
Zhengzhou 18
Buenos Aires 17
São Paulo 17
Ningbo 16
Amman 15
Ankara 15
Chicago 15
Nanchang 15
Padova 15
Trieste 15
Belgrade 14
Hangzhou 14
Zurich 14
Barcelona 13
Brussels 13
Cape Town 13
Council Bluffs 13
Falls Church 13
Hebei 13
Selby 13
Sydney 13
Athens 12
Seoul 12
Sunnyvale 12
Warsaw 12
Bergamo 11
Bogotá 11
Hefei 11
Jiaxing 11
Kilcock 11
San Francisco 11
Torino 11
Central 10
Dong Ket 10
Kashima-shi 10
Kyoto 10
Mexico 10
Montreal 10
Auckland 9
Budapest 9
Graz 9
Hyderabad 9
Kuala Lumpur 9
Los Angeles 9
Medford 9
Mumbai 9
Nottingham 9
Perth 9
Totale 5.956
Salva come PNG Salva come JPEG
Nome #
Effect of soy on metabolic syndrome and cardiovascular risk factors : a randomized controlled trial 1.511
Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study 736
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 603
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters 431
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 380
Efficacy and safety of lomitapide in homozygous familial hypercholesterolaemia: the pan-European retrospective observational study 338
The PPAR pan-agonist tetradecylthioacetic acid promotes redistribution of plasma cholesterol towards large HDL 337
A proteomic approach to identify novel disease biomarkers in LCAT deficiency 319
Treatment with fibrates is associated with higher LAL activity in dyslipidemic patients 312
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 275
Nutraceutical approach for the management of cardiovascular risk – a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract : results from a randomized, double-blind, placebo-controlled study 273
Influence of body variables in the development of metabolic syndrome : A long term follow-up study 222
Lipid-lowering therapy of everolimus-related severe hypertriglyceridaemia in a pancreatic neuroendocrine tumour (pNET) 190
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting : the PROSISA Study 180
Nutraceutical approach to moderate cardiometabolic risk : results of a randomized, double-blind and crossover study with Armolipid Plus 176
Systematic Lab Knowledge Integration for Management of Lipid Excess in High-Risk Patients : Rationale and Design of the SKIM LEAN Project 172
Valutazione dei benefici salutistici dell'assunzione dI proteine della soia in pazienti con moderata sindrome metabolica 170
GENETIC LCAT DEFICIENCY AND ATHEROSCLEROSIS: STUDIES ON ENDOTHELIAL CELLS AND MONOCYTES 164
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 162
Evaluation of the health benefits of soy protein consumption in patients carrying the metabolic syndrome 152
Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes : evidence in NAFLD patients and cell cultures 146
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 138
Progression of chronic kidney disease in Familial LCAT Deficiency: a follow-up of the Italian cohort 136
Interactions of Oxysterols with Atherosclerosis Biomarkers in Subjects with Moderate Hypercholesterolemia and Effects of a Nutraceutical Combination (Bifidobacterium longum BB536, Red Yeast Rice Extract) (Randomized, Double-Blind, Placebo-Controlled Study) 134
Effects of a lupin protein concentrate on lipids, blood pressure and insulin resistance in moderately dyslipidaemic patients : a randomised controlled trial 121
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency 119
Dysfunctional HDL as a therapeutic target for atherosclerosis prevention 107
Considering gender in prescribing statins : what do physicians need to know? 105
Appropriateness of statin prescription in the elderly 102
Activation of naturally occurring LCAT mutants by a novel activator compound 102
Novel therapeutic strategies for the homozygous familial hypercholesterolemia 97
Genetic and phenotypic characterization of LDL-receptor in patients with a clinical diagnosis of familial hypercholesterolemia: two novel mutations 97
Autosomal recessive hypercholesterolemia : long-term cardiovascular outcomes 93
Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH) : a cross-national retrospective survey 91
Genetic characterization of LDL-receptor in patients with a clinical diagnosis of familial hypercholesterolemia: two novel mutations 89
Gender-related lipid and/or lipoprotein responses to statins in subjects in primary and secondary prevention 88
Soya-enriched mixed diet significantly improves cardiovascular and metabolic risk factors : A randomized controlled trial 86
The HDL mimetic CER-001 remodels plasma lipoproteins and reduces kidney lipid deposits in inherited lecithin:cholesterol acyltransferase deficiency 86
CA-IMT and QT parameters in dyslipidemic patients in primary prevention at different ESC/EAS cardiovascular risk levels 85
Nutraceutical approaches to metabolic syndrome 83
The relation of serum lipoprotein (a) concentration and apolipoprotein (a) phenotype with preclinical atherosclerosis 77
Cardiovascular determinants of QT interval duration in dysplipidemic patients in primary prevention in two genders 75
Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020 74
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 72
Gender-specific comparison of six QT correction formulae in dyslipidemic patients in primary prevention 70
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD) 68
Microsomal transfer protein (MTP) inhibition : a novel approach to the treatment of homozygous hypercholesterolemia 67
Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos) 65
Lipoprotein (a) : concentration, isoforms, polymorphisms and association with preclinical atherosclerosis 63
Plasma lipoproteins of patients with genetic LAL deficiency are enriched in cholesteryl esters: Relevance of cholesterol esterification by LCAT 61
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 61
High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis 57
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 57
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia : Results of a Real-World Clinical Experience in Italy 55
Three new italian cases of LCAT deficiency 54
Spring Meeting of the Young Researchers of SID, SIIA, SIMI, SIPREC, SISA 43
Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia 42
Response to treatment and occurrence of cardiovascular (CV) complications in patients with autosomal recessive hypercholesterolemia (ARH): A retrospective analysis 41
Plasma FA composition in familial LCAT deficiency indicates SOAT2-derived cholesteryl ester formation in humans 40
Efficacy of Long-Term Treatment of Autosomal Recessive Hypercholesterolemia With Lomitapide: A Subanalysis of the Pan-European Lomitapide Study 38
HDL and chronic kidney disease 38
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study 37
Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer's disease 36
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group 35
Effects of PCSK9 inhibitors on HDL cholesterol efflux and serum cholesterol loading capacity in familial hypercholesterolemia subjects: a multi-lipid-center real-world evaluation 33
Apolipoprotein E isoforms differentially affect LCAT-dependent cholesterol esterification 31
Abnormal Lipoproteins Trigger Oxidative Stress-Mediated Apoptosis of Renal Cells in LCAT Deficiency 27
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency 22
Two novel variants in the lecithin:cholesterol acyltransferase gene resulted in classic LCAT deficiency 21
Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production 16
Evaluation of high-density lipoprotein-bound long non-coding RNAs in subjects with familial hypercholesterolaemia 14
Flipped C-Terminal Ends of apoA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs 14
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 13
Emerging Therapies for Familial Lecithin-Cholesterol Acyltransferase Deficiency: A Role for Plasma Exchange 10
Exploiting routine laboratory test to identify primary severe hypertriglyceridaemic patients in a large Italian hospital 7
Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia 7
Familial LCAT deficiency and cardiovascular disease: the game is not over. A case of dramatic multivessel atherosclerosis 5
Totale 10.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.564
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.505 0 62 67 151 106 184 197 145 229 198 80 86
2020/20211.812 145 122 112 145 149 148 148 162 184 244 138 115
2021/20221.651 111 114 123 157 134 170 116 110 161 145 115 195
2022/20231.917 127 124 108 104 172 235 145 179 236 126 213 148
2023/20241.918 169 188 198 249 321 95 90 116 67 94 163 168
2024/2025182 128 54 0 0 0 0 0 0 0 0 0 0
Totale 10.754